Ginkgo Bioworks Inc. (NYSE: DNA), the cell programming company which previously combined with Soaring Eagle Acquisition Corp. in September of 2021, announced this morning that it would be buying the biotech company Zymergen (Nasdaq: ZY), in an all-stock transaction.
Ginkgo will be acquiring Zymergen at a fixed exchange ratio of 0.9179 Ginkgo shares for each Zymergen share, which puts the value of ZY at approximately $2.85 per share.
What’s probably most interesting to SPAC investors is that while Ginkgo is a former SPAC, Zymergen came public via a $500 million traditional IPO in April of 2021, at a price of $31.00. Zymergen’s announced acquisition price today of $2.85/share represents a value -91% lower than ZY’s IPO offer price.
But, Zymergen had a pretty storied and grim start to public company status from the get-go. Just three months after going public, ZY announced severe cutbacks in its commercial pipeline virtually wiping out any chance of generating revenue in 2021. At that point, the share price tumbled 75% and the founder and CEO stepped down. Keep in mind that this was a traditional IPO that was sold based on its commercial pipeline.
So to have a SPAC buying a traditional IPO on the cheap after said traditional IPO failed to execute on what it sold during its roadshow, completely turns the current narrative about SPACs on its head.
In other SPAC news, Infrastructure and Energy Alternatives Inc. (Nasdaq: IEA), another former SPAC that combined with M III Acquisition Corp. in March of 2018, announced that it will be acquired by MasTec (NYSE: MTZ), a leading infrastructure construction company, for approximately $14.00 per share, a 40% premium to M III’s IPO price of $10.00.
IEA is a services provider in renewable energy and infrastructure solutions with extensive expertise and capabilities spanning engineering, procurement, construction and other related services. M III, originally raised $150 million at its July 2016 IPO and announced its combination with IEA in 2017 with an implied enterprise value at that time of $293 million.
Both deals today paint a different picture than what’s usually portrayed in the press. Namely, that not every traditional IPO is a success; not every SPAC is a failure. And, even without using projections in a traditional IPO, there is no guarantee the company is accurately portraying its commercial viability.
And lastly, perhaps the recent volatility that has inhibited IPO activity ramps up the M&A market as the macro-economic backdrop moderates. After all, lots of good bargains out there…
Terms Tracker for the Week Ending May 23, 2025 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. Another solid week for SPAC IPO trading. Five more IPOs priced, bringing May’s total to 18 and the YTD tally to 49. That’s just eight...
Pelican Acquisition Corp. (NASDAQ:PELIU) announced the pricing of its $75 million IPO and its units began trading on the Nasdaq under the symbol “PELIU”, Friday, May 23, 2025. The new SPAC aims to combine with a technology company with a defensible market position that would benefit from being publicly traded in the US. Pelican’s management...
Cohen Circle II (NASDAQ:CCIIU) has filed for a $220 million SPAC marking the second wave of the Betsy Cohen team’s return to the market in the burgeoning 2024/2025 cycle. The new SPAC brings slightly less warrant coverage than its predecessor Cohen Circle I (NASDAQ:CCIR) with a 1/4 warrant in each of its units as opposed...
A Paradise (NASDAQ:APADU) has filed for a $200 million SPAC to get a fresh Asia-focused vehicle on the road with a leader that has steered several SPACs before. The new SPAC continues underwriter Cohen & Company’s warpath as its 15th SPAC put on file this year, with the firm’s 12th SPAC IPO debut set for...
On this week’s SPACInsider REPLAY, we revisit a 2022 conversation with Harry Sloan of the Eagle SPACs. At the time, Harry had already completed seven SPACs and was closing in on his eighth. As markets cooled and the SPAC boom waned, Harry offered a prescient take on where the market was headed—and what a “post-boom”...